Meibomian gland alterations in polycystic ovary syndrome

Current Eye Research

Volumn 33, Issue 2, 2008, Pages 133-138

  Yavas, Guliz Fatma ^a,b   Ozturk, Faruk ^a   Kusbeci, Tuncay ^a   Ermis, Sitki Samet ^a   Yilmazer, Mehmet ^a   Cevrioglu, Serhan ^a   Aktepe, Fatma ^a   Kose, Songul ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b Department of Obstetrics and Gynecology ^*  (Turkey)

Author keywords

Hyperandrogenism; Hyperinsulinemia; Meibomian gland dysfunction; Polycysticovary syndrome; Schirmer test

Indexed keywords

ROSE BENGAL;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DRY EYE; FEMALE; GOBLET CELL; HISTOLOGY; HUMAN; LIPID BILAYER; MEIBOMIAN GLAND; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCHIRMER TEST; TEAR FILM;

ADULT; CELL COUNT; DRY EYE SYNDROMES; EYELID DISEASES; FEMALE; HUMANS; MEIBOMIAN GLANDS; POLYCYSTIC OVARY SYNDROME; TEARS;

EID: 39749202197     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701858410     Document Type: Article

References (32)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745-2749.
2. Michelmore KF, Balen AH, Dunger DB, Vessey MB. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. 1999;51:779-786.
3. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006-4011.
4. Asuncion M, Calvo RM, Millan JLS, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434-2438.
5. Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83-89.
6. Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45:211-220.
7. McCulley JP, Shine WE. The lipid layer of tears: Dependent on meibomian gland function. Exp Eye Res. 2004;78:361-365.
8. Sutphin JE, Chodosh J, Dana MR, et al. Normal physiology of the ocular surface. In: Liesegang TJ, Skuta GL, Cantor LB, eds. Basic and Clinical Science Course External Disease and Cornea. San Francisco: American Academy of Ophthalmology; 2005: 47-52.
9. Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci. 2000;41:3732-3742.
10. Bron AJ, Tiffany JM. The meibomian glands and tear film lipids. In: Sullivan DA, Dartt DA, Meneray MA, eds. Advances in Experimental Medicine and Biology: Lacrimal Gland, Tear film, and Dry Eye Syndromes. 2. Basic Science and Clinical Relevance. New York: Plenum; 1998: 281-295.
11. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000;85:4874-4882.
12. Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril. 2004;81:361-366.
13. Bonini S, Mantelli F, Moretti C, Lambiase A, Bonini S, Micera A. Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol. 2007;143:763-771.
14. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-1447.
15. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
16. Lin PY, Cheng CY, Hsu WM, et al. Association between symptoms and elderly Chinese population in Taiwan: The Shihpai Eye Study. Invest Ophthalmol Vis Sci. 2005;46:1593-1598.
17. van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;82:10-14.
18. Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol. 1984;102:1049-1052.
19. Kari O, Aho VV, Peltonen S, et al. Group IIA phospholipase A(2) concentration of tears in patients with ocular rosacea. Acta Ophthalmol Scand. 2005;83:483-486.
20. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population based perspective. Ophthalmology. 1997;104:1395-1401.
21. Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006;12:324-332.
22. Alves M, Cunha DA, Calegari VC, et al. Nuclear factor-kappa B and advanced glycation end-products expression in lacrimal glands of aging rats. J Endocrinol. 2005;187:159-166.
23. Alves M, Calegari VC, Cunha DA, Saad MJ, Velloso LA, Rocha EM. Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats. Diabetologia. 2005;48:2675-2681.
24. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ohthalmol. 1995;113:1266-1270.
25. Rocha EM, Wickham LA, da Silveira LA, et al. Identification of androgen receptor protein and 5-alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol. 2000;84:76-84.
26. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann NY Acad Sci. 2002;966:211-222.
27. Erdem U, Ozdegirmenci O, Sobac? E, Sobaci G, Göktolga U, Dagli S. Dry eye in post-menopausal women using hormone replacement therapy. Maturitas. doi:10.1016/j.maturitas.2006.08.007
28. Schirra F, Richards SM, Liu M, Suzuki T, Yamagami H, Sullivan DA. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res. 2006;83:291-296.
29. Mathers WD, Stovall D, Lane JA, Zimmerman MB, Johnson S. Menopause and tear function: The influence of prolactin and sex hormones on human tear production. Cornea. 1998;17:353-358.
30. Labrie F, Bélanger A, Luu-The V, et al. Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues. In: Thijssen JHH and Nieuwenhuyse H, eds. Proceedings of the Workshop on DHEA: A Comprehensive Review, Amsterdam, 1997. New York: Parthenon Publishing; 1999: 69-103.
31. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2760-2766.
32. Schirra F, Suzuki T, Dickinson DP, Townsend DJ, Gipson IK, Sullivan DA. Identificantion of steroidogenic enzyme mRNAs in the human lacrimal gland, meibomian gland, cornea, and conjunctiva. Cornea. 2006;25:438-442.